We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Heat Wrap Device Safety With Age and Body Fat

This study has been completed.
ClinicalTrials.gov Identifier:
First Posted: May 18, 2011
Last Update Posted: August 29, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
This study is designed to compare the safety, as measured by skin findings and adverse events, of two different heat devices in elderly, overweight, and elderly and overweight subjects.

Condition Intervention
Back Pain Device: thermal therapy Device: marketed heatwrap

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Official Title: An Open Label Study To Compare The Effects Of Age And Body Fat On The Safety Of Two Heat Wrap Devices In Healthy Subjects

Further study details as provided by Pfizer:

Primary Outcome Measures:
  • Percentage of subjects with any thermal-related skin events (defined as elevated skin response, erythema ≥ 2.0 [moderate], or pain upon touch plus non-zero erythema) [ Time Frame: morning after product wear through 15 days after last product application ]

Secondary Outcome Measures:
  • Percentage of subjects with any adverse event [ Time Frame: during and after wear for 28 days after last wear ]

Estimated Enrollment: 57
Study Start Date: April 2011
Study Completion Date: July 2011
Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Treatment A
thermal therapy
Device: thermal therapy
heat therapy device, topical, two applications, at 0-3 hours and 4-6 hours on treatment day
Active Comparator: Treatment B
ThermaCare Lower Back/Hip heatwrap
Device: marketed heatwrap
heatwrap, topical, one time application, 8 hour duration

Detailed Description:
Safety measurements

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 84 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Males or females in generally good health, and who are either 18-54 years of age with a body mass index of ≥ 30 kg/m2
  • or 55-84 years of age and with a body mass index ≥ 30 kg/m2 or < 30 kg/m2
  • Females who are not pregnant or breastfeeding
  • Subject is medically cleared for study participation

Exclusion Criteria:

  • No sensitivity or allergy to device components in contact with skin
  • Diabetes
  • Any active skin disease or tattoos at the test site that would affect participation
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01355653

United States, California
Pfizer Investigational Site
Loma Linda, California, United States, 92350
Sponsors and Collaborators
Study Director: Pfizer CT.gov Call Center Pfizer
  More Information

Additional Information:
Responsible Party: Pfizer
ClinicalTrials.gov Identifier: NCT01355653     History of Changes
Other Study ID Numbers: B3571002
First Submitted: April 28, 2011
First Posted: May 18, 2011
Last Update Posted: August 29, 2011
Last Verified: August 2011

Keywords provided by Pfizer:

Additional relevant MeSH terms:
Back Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms